Loading data for SMTI — first visit, this takes a few seconds.

Sanara MedTech Inc. (SMTI)

NasdaqCM: SMTI · Real-Time Price · USD

34.73

+0.01 (0.03%)

At close: Sep 04, 2026, 8:00 PM

34.72

-0.03%

After-hours: 7:30 PM

Alert

The price, the headline numbers and the latest news, in one place.

No data available

Bid	24.74
Market Cap	319M
Revenue (ttm)	110M
Net Income (ttm)	-285K
	1.16
	-0.04
	n/a
	64.31
P/B (ttm)	45.28
P/S (ttm)	2.91
Earnings Date	Nov 11, 2026

Ask	44.78
Volume	541,686
Avg. Volume (20D)	230,341
Open	34.62
Previous Close	34.72
Day's Range	34.62 - 34.79
52-Week Range	16.05 - 35.95
Analyst	n/a
Price Target	n/a
Dividends	n/a
Ex-Dividend Date	n/a

About SMTI

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-ri...

[Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

IPO Date Apr 7, 1994

Employees 108

Stock Exchange NasdaqCM

Ticker Symbol SMTI

Website https://sanaramedtech.com

Full Company Profile

Financial Performance

In 2025, Sanara MedTech's revenue was 103.12M, an increase of 18.97% compared to the previous year's 86.67M. Earnings were -37.56M, an increase of 288.66%.

Financial Statements

Earnings Surprise

Sanara MedTech has released their quarterly earnings on Aug 11, 2026:

Revenue of $27.8M misses estimates by $0, with 18.62% YoY growth.
EPS of 0.09 exceeds estimates by 0.16, with 139.13% YoY growth.

Next Earnings Release

Sanara MedTech Inc. is scheduled to release its earnings on Nov 11, 2026, during market hours.
Analysts project revenue of ... Upgrade

Why Price Moved

News

3 weeks ago · Zacks

Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates

Sanara MedTech (SMTI) delivered earnings and revenue surprises of +150.00% and -4.30%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago · Motley Fool

MiMedx (MDXG) Q2 2026 Earnings Call Transcript

Surgical revenue grew 15% as wound care stabilized ahead of $350M Sanara deal.

4 weeks ago · Zacks

biote Corp. (BTMD) Reports Break-Even Earnings for Q2

biote Corp. (BTMD) delivered earnings and revenue surprises of -100.00% and -5.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

1 month ago · Moby

MiMedx Group, Inc. Q2 2026 Earnings Call Summary

Moby summary of MiMedx Group, Inc.'s Q2 2026 earnings call

1 month ago · GuruFocus.com

MiMedx Group Inc (MDXG) (Q2 2026) Earnings Call Highlights: Surgical Growth and Transformative ...

MiMedx reports strong surgical momentum and a transformational acquisition, while navigating a challenging wound care market with early signs of stabilization.

Page 1 of 2

Sanara MedTech Inc. (SMTI)